X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1745) 1745
Book Review (281) 281
Publication (73) 73
Newsletter (68) 68
Book Chapter (17) 17
Magazine Article (17) 17
Conference Proceeding (14) 14
Newspaper Article (7) 7
Dissertation (3) 3
Trade Publication Article (3) 3
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pramipexole (1674) 1674
index medicus (1043) 1043
humans (858) 858
parkinson's disease (655) 655
clinical neurology (651) 651
male (583) 583
female (465) 465
parkinson disease - drug therapy (428) 428
neurosciences (424) 424
middle aged (402) 402
ropinirole (374) 374
double-blind (360) 360
aged (358) 358
dopamine (351) 351
levodopa (344) 344
pharmacology & pharmacy (341) 341
dopamine agonists - therapeutic use (308) 308
restless legs syndrome (245) 245
adult (228) 228
antiparkinson agents - therapeutic use (225) 225
psychiatry (225) 225
animals (224) 224
parkinsons-disease (223) 223
dopamine agonists (215) 215
treatment outcome (179) 179
drug therapy (177) 177
neurology (168) 168
dopamine agonist (165) 165
dopamine agonists - adverse effects (162) 162
sleep (160) 160
benzothiazoles - therapeutic use (157) 157
restless legs syndrome - drug therapy (156) 156
depression (150) 150
dose-response relationship, drug (146) 146
benzothiazoles (143) 143
severity of illness index (142) 142
double-blind method (141) 141
dopamine agonists - pharmacology (138) 138
pergolide (136) 136
rats (136) 136
antiparkinson agents - adverse effects (135) 135
efficacy (134) 134
parkinson disease - complications (133) 133
levodopa - therapeutic use (130) 130
research (121) 121
bromocriptine (120) 120
dopamine agonists - administration & dosage (118) 118
placebo (116) 116
analysis (113) 113
parkinson disease - physiopathology (108) 108
aged, 80 and over (106) 106
abridged index medicus (98) 98
dosage and administration (98) 98
l-dopa (98) 98
care and treatment (95) 95
parkinsons disease (95) 95
medicine, general & internal (94) 94
therapy (94) 94
benzothiazoles - pharmacology (93) 93
risk factors (93) 93
placebo-controlled trial (92) 92
diagnosis (89) 89
benzothiazoles - adverse effects (86) 86
movement disorders (86) 86
parkinson’s disease (86) 86
benzothiazoles - administration & dosage (83) 83
time factors (82) 82
cabergoline (81) 81
dopamine receptors (78) 78
medicine & public health (78) 78
randomized controlled-trial (78) 78
rotigotine (78) 78
thiazoles - therapeutic use (78) 78
agonists (77) 77
augmentation (77) 77
antiparkinsonian agents (76) 76
medical research (76) 76
complications and side effects (73) 73
motor fluctuations (73) 73
multicenter (73) 73
management (72) 72
neurodegenerative diseases (71) 71
phenols (71) 71
clinical trials (70) 70
drug therapy, combination (70) 70
quality of life (70) 70
mice (69) 69
prevalence (69) 69
dopa (68) 68
medicine, experimental (68) 68
neuroprotection (68) 68
antiparkinson agents - administration & dosage (67) 67
brain (67) 67
controlled-trial (67) 67
quality-of-life (67) 67
dopamine - metabolism (66) 66
drugs (66) 66
levodopa - adverse effects (64) 64
prospective studies (64) 64
indoles - therapeutic use (63) 63
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1746) 1746
German (38) 38
Spanish (26) 26
Russian (19) 19
French (8) 8
Turkish (7) 7
Japanese (5) 5
Polish (5) 5
Portuguese (3) 3
Chinese (2) 2
Hungarian (2) 2
Dutch (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CNS spectrums, ISSN 1092-8529, 02/2019, Volume 24, Issue 1, pp. 185 - 186
IntroductionThe association of sleep disorders and post-traumatic stress disorder (PTSD) is almost universal. Nightmares are not only one of the most commonly... 
PTSD | Pramipexole | Nightmares
Journal Article
Folia Medica, 06/2019, Volume 61, Issue 2, pp. 258 - 265
Background: Parkinson’s disease (PD) is the second most common neurode-generative disease, usually detected by its motor symptoms. The non-motor symptoms,... 
haloperidol | learning | memory | pramipexole
Journal Article
Journal Article
R & D Focus Drug News, ISSN 1350-1135, 03/2019
Journal Article
by Park, D
PARKINSONISM & RELATED DISORDERS, ISSN 1353-8020, 05/2017, Volume 38, pp. 106 - 107
Journal Article
Neuropharmacology, ISSN 0028-3908, 07/2019, Volume 152, pp. 51 - 57
Receptor-receptor interactions are essential to fine tune receptor responses and new techniques enable closer characterization of the interactions between... 
Dopamine 2 receptor | GPR37 | GPR37L1 | Pramipexole | 4-PBA fluorescence cross-correlation spectroscopy | 4-PHENYLBUTYRATE | PAEL-R | TRAFFICKING | CROSS-CORRELATION SPECTROSCOPY | DEATH | TOXICITY | ENDOPLASMIC-RETICULUM STRESS | FLUORESCENCE CORRELATION SPECTROSCOPY | NEUROSCIENCES | PHARMACOLOGY | PHARMACOLOGY & PHARMACY | PRAMIPEXOLE PROTECTS
Journal Article
Journal Article
Sleep Medicine, ISSN 1389-9457, 07/2019, Volume 59, pp. 117 - 118
Journal Article
Journal Article
ACTAS ESPANOLAS DE PSIQUIATRIA, ISSN 1139-9287, 03/2017, Volume 45, Issue 2, pp. 80 - 83
Journal Article
Medicine (United States), ISSN 0025-7974, 07/2017, Volume 96, Issue 28
Journal Article
Journal Article
Parkinsonism and Related Disorders, ISSN 1353-8020, 09/2016, Volume 30, pp. 13 - 17
Impulse control disorders (ICD) are reported to occur at variable frequencies in different ethnic groups. Genetic vulnerability is suspected to underlie the... 
Ropinirole | Impulse control | DRD3 | Parkinson’s disease | Pramipexole
Journal Article
Pharmacology and Therapeutics, ISSN 0163-7258, 11/2010, Volume 128, Issue 2, pp. 229 - 273
Though l-3,4-dihydroxyphenylalanine (L-DOPA) is universally employed for alleviation of motor dysfunction in Parkinson's disease (PD), it is poorly-effective... 
α | Ropinirole | Pergolide | receptor | D | Antiparkinson | Adrenoceptor | Pramipexole
Journal Article
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, ISSN 0928-4931, 10/2018, Volume 91, pp. 64 - 77
Journal Article
European Psychiatry, ISSN 0924-9338, 2015, Volume 30, Issue 8, pp. S58 - S58
Du fait de l’analogie entre apathie et dépression [1,2] , nous avons utilisé le pramipexole [3] chez 64 patients déprimés (39 patients présentant une... 
Internal Medicine | Psychiatry | Dépression résistante | Pramipexole
Journal Article
Neurology, ISSN 0028-3878, 12/2018, Volume 91, Issue 24, pp. e2238 - e2243
OBJECTIVETo assess dyskinesia frequency in a population-based cohort of patients with Parkinson disease (PD). Dyskinesia complicates levodopa treatment and... 
PRAMIPEXOLE | MOTOR FLUCTUATIONS | OLMSTED COUNTY | CLINICAL NEUROLOGY | Index Medicus | Abridged Index Medicus
Journal Article
Pharmacological Reports, ISSN 1734-1140, 10/2018, Volume 70, Issue 5, pp. 1010 - 1014
Parkinson’s disease (PD) is one of the most common serious neurodegenerative disorders in the world. The incidence of PD appears to be growing and this illness... 
Sphingosine kinase 1 | Fingolimod | Pramipexole | Parkinson’s disease | Sphingosine-1-phosphate
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.